Authors
This author contributed to 83 pathways:
This author contributed to 83 pathways:
Larsgw
Lars Willighagen
https://larsgw.github.io/
- GitHub: larsgw
- ORCiD: 0000-0002-4751-4637
- Google Scholar: r9lmG00AAAAJ
- Wikidata: Q45907528
- Twitter: larswillighagen
- Mastodon: https://mastodon.social/@larsgw
Communities
Pathways
This author contributed to 83 pathways:
This author contributed to 83 pathways:
- Markers of kidney cell lineage - WP5236 (Homo sapiens)
- GDNF/RET signaling axis - WP4830 (Homo sapiens)
- Kallmann syndrome - WP5074 (Homo sapiens)
- T-cell activation SARS-CoV-2 - WP5098 (Homo sapiens)
- Estradiol regulation in porto-sinusoidal vascular disease - WP5235 (Homo sapiens)
- Ovarian infertility - WP34 (Homo sapiens)
- Th17 cell differentiation pathway - WP5130 (Homo sapiens)
- Network map of SARS-CoV-2 signaling - WP5115 (Homo sapiens)
- DYRK1A involvement regarding cell proliferation in brain development - WP5180 (Homo sapiens)
- Prader-Willi and Angelman syndrome - WP3998 (Homo sapiens)
- ADHD and autism (ASD) pathways - WP5420 (Homo sapiens)
- Affected pathways in Duchenne muscular dystrophy - WP5356 (Homo sapiens)
- Disorders of fructose metabolism - WP5178 (Homo sapiens)
- SARS-CoV-2 B.1.1.7 variant antagonises innate immune activation - WP5116 (Homo sapiens)
- Meta pathway lipodystrophy, dyslipidemia and hyperlipidemia - WP5105 (Homo sapiens)
- Complement system - WP2806 (Homo sapiens)
- TCA cycle - WP999 (Bos taurus)
- 7q11.23 distal copy number variation - WP5401 (Homo sapiens)
- Smith-Magenis and Potocki-Lupski syndrome copy number variation - WP5381 (Homo sapiens)
- Lacto series sphingolipid metabolism - WP5303 (Homo sapiens)
- Ganglio series sphingolipid metabolism - WP5299 (Homo sapiens)
- Disorders of galactose metabolism - WP5173 (Homo sapiens)
- Burn wound healing - WP5057 (Rattus norvegicus)
- Kynurenine pathway and links to cell senescence - WP5044 (Homo sapiens)
- Pentose phosphate pathway in senescent cells - WP5043 (Homo sapiens)
- SARS-CoV-2 innate immunity evasion and cell-specific immune response - WP5039 (Homo sapiens)
- TCA cycle - WP490 (Saccharomyces cerevisiae)
- Fragile X syndrome - WP4549 (Homo sapiens)
- Flavan-3-ol metabolic pathway - WP4238 (Homo sapiens)
- Quercetin and Nf-kB / AP-1 induced cell apoptosis - WP3167 (Bos taurus)
- Seed development - WP2279 (Arabidopsis thaliana)
- Seed development - WP2199 (Oryza sativa)
- Folic acid network - WP1311 (Rattus norvegicus)
- Folic acid network - WP1273 (Mus musculus)
- Resolvin E1 and resolvin D1 signaling decrease inflammation - WP5191 (Homo sapiens)
- NIPBL role in DNA damage - Cornelia de Lange syndrome - WP5119 (Homo sapiens)
- SMC1/SMC3 role in DNA damage - Cornelia de Lange Syndrome - WP5118 (Homo sapiens)
- Poly(glycerol phosphate) wall teichoic acid biosynthesis - WP4162 (Saccharomyces cerevisiae)
- Flowering time pathway - WP2625 (Hordeum vulgare)
- Evolocumab mechanism to reduce LDL cholesterol - WP3408 (Homo sapiens)
- Steroid hormone precursor biosynthesis - WP5277 (Homo sapiens)
- Neurotransmitter disorders - WP4220 (Homo sapiens)
- Genetic causes of porto-sinusoidal vascular disease - WP5269 (Homo sapiens)
- Disorders in ketone body synthesis - WP5175 (Homo sapiens)
- Phase I biotransformations, non-P450 - WP1291 (Rattus norvegicus)
- Phase I biotransformations, non-P450 - WP1213 (Equus caballus)
- Phase I biotransformations, non-P450 - WP1021 (Bos taurus)
- Sphingolipid metabolism in senescence - WP5121 (Homo sapiens)
- Purine metabolism - WP2185 (Mus musculus)
- Nucleotide excision repair - WP4753 (Homo sapiens)
- Base excision repair - WP4752 (Homo sapiens)
- Non-homologous end joining - WP438 (Homo sapiens)
- Wnt signaling pathway and pluripotency - WP1288 (Rattus norvegicus)
- Primary ovarian insufficiency - WP5316 (Homo sapiens)
- Kennedy pathway from sphingolipids - WP3933 (Homo sapiens)
- Pleural mesothelioma - WP5087 (Homo sapiens)
- Wnt signaling pathway and pluripotency - WP779 (Gallus gallus)
- ATM signaling pathway - WP654 (Rattus norvegicus)
- Glycerol teichoic acid biosynthesis - WP563 (Saccharomyces cerevisiae)
- PtdIns(4,5)P2 in cytokinesis pathway - WP5199 (Homo sapiens)
- Leukotriene metabolic pathway - WP5171 (Homo sapiens)
- Catecholamine synthesis - WP513 (Rattus norvegicus)
- GDNF/RET signaling axis - WP4820 (Mus musculus)
- Oxidative stress and redox pathway - WP4466 (Mus musculus)
- Metabolism of tetrahydrocannabinol (THC) - WP4174 (Homo sapiens)
- SK UDPglcnac - WP3641 (Escherichia coli)
- Primary focal segmental glomerulosclerosis (FSGS) - WP3233 (Bos taurus)
- SREBF and miR33 in cholesterol and lipid homeostasis - WP3137 (Bos taurus)
- Cardiac progenitor differentiation - WP3127 (Bos taurus)
- Primary carbon metabolism - WP2859 (Populus trichocarpa)
- Pentose phosphate pathway - WP282 (Rattus norvegicus)
- Glycolysis - WP2621 (Arabidopsis thaliana)
- Primary focal segmental glomerulosclerosis (FSGS) - WP2573 (Mus musculus)
- Cardiolipin biosynthesis - WP2208 (Oryza sativa)
- SREBF and miR33 in cholesterol and lipid homeostasis - WP2084 (Mus musculus)
- DNA replication - WP192 (Caenorhabditis elegans)
- Carbon assimilation C4 pathway - WP1493 (Zea mays)
- Oxidation by cytochrome P450 - WP1274 (Mus musculus)
- Translation factors - WP110 (Caenorhabditis elegans)
- Oxidation by cytochrome P450 - WP1077 (Bos taurus)
- Pentose phosphate pathway - WP1028 (Bos taurus)
- mRNA processing - WP123 (Caenorhabditis elegans)
- Acetogenesis - WP5019 (Acetobacterium woodii)